Kenvue Inc. (KVUE) Análise de ações

Visão geral da empresa

Kenvue Inc. operates as a leading consumer health company with a significant presence across the United States, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The corporation generates its revenue through three primary segments: Self Care, Skin Health and Beauty, and Essential Health, offering a diverse portfolio of over-the-counter medicine and personal care products. This business model places the company firmly within the Consumer Defensive sector, specifically under the Household & Personal Products industry, which typically implies stable demand driven by essential consumer needs rather than cyclical economic factors. The company demonstrates substantial scale with a market capitalization of $33.24B and an annual revenue of $15.12B, supported by a workforce of 21,780 employees globally. These valuation and revenue figures indicate that Kenvue holds a dominant position in its respective market, commanding a large capitalization that reflects its established brand portfolio and widespread distribution network essential for a defensive consumer staple.

Saúde financeira

Kenvue reported a trailing twelve-month revenue of $15.12B, generating a net income of $1.47B and an EBITDA of $3.24B during the same period. The substantial gap between the $15.12B revenue and the $1.47B net income reveals a significant cost structure where approximately 90% of revenue is consumed by costs of goods sold, operating expenses, and taxes before arriving at the bottom line. However, the EBITDA of $3.24B suggests robust operational cash generation before interest and non-cash charges, providing a clearer picture of underlying business performance. The company generated $1.81B in free cash flow, which indicates strong financial flexibility to fund capital expenditures, manage debt obligations, or return capital to shareholders without relying on external financing. Profitability is further detailed through three key margins: a gross margin of 58.4%, an operating margin of 17.8%, and a profit margin of 9.7%. The high gross margin of 58.4% indicates strong pricing power and efficient supply chain management relative to the cost of products, while the operating margin of 17.8% reflects effective control over administrative and selling expenses. The profit margin of 9.7% shows the final profitability after all obligations, including interest and taxes. Regarding liquidity and leverage, Kenvue holds $1.06B in cash against a total debt load of $8.67B, resulting in a debt-to-equity ratio of 80.58, which characterizes a leveraged balance sheet dependent on steady cash flows to service obligations. The current ratio stands at 0.96, indicating that the company's current assets are slightly lower than its current liabilities, suggesting a tight short-term liquidity position that requires efficient working capital management. Return metrics show a return on equity of 14.4% and a return on assets of 6.6%, revealing that management is effective at generating returns on the equity invested by shareholders, though the return on assets is moderated by the company's high debt levels.

Avaliação de valorização

The valuation of Kenvue is assessed using a trailing P/E ratio of 22.82 and a forward P/E of 14.30. The significant difference between the trailing P/E of 22.82 and the forward P/E of 14.30 implies that the market expects earnings to grow substantially in the future, as the current price is high relative to past earnings but low relative to projected earnings. The price-to-book ratio is 3.09, which indicates that the market values the company at a significant premium over its net book value, reflecting the intangible value of its brands and distribution networks. Alternative valuation metrics, including a price-to-sales ratio of 2.20 and an EV/EBITDA of 12.60, suggest that investors are pricing the stock based on its revenue generation and earnings power relative to enterprise value, providing a different perspective than the P/E multiple alone. The stock's recent trading range is defined by a 52-week high of $25.17 and a 52-week low of $14.02. To determine the current position relative to this range, one must note that the forward P/E of 14.30 is significantly lower than the trailing P/E, suggesting a potential compression of valuation multiples if earnings do not meet high expectations, while the price-to-sales ratio of 2.20 provides context on revenue valuation. The beta value of 0.57 indicates that the stock exhibits low price volatility relative to the broader market, moving less than half as much as the market index on average. This low beta suggests that Kenvue may serve as a stabilizing component in a portfolio, offering less sensitivity to market swings compared to high-beta growth stocks.

Growth & Income

The company's recent performance includes a revenue growth of 3.2% year-over-year and an earnings growth of 11.2% year-over-year. The fact that earnings are growing at 11.2% while revenue grows at only 3.2% implies that the company is improving its profitability through margin expansion, cost controls, or a shift toward higher-margin product mixes rather than pure volume growth. As a dividend payer, Kenvue offers a dividend yield of 4.8% to shareholders, though the payout ratio stands at 108.5%. This payout ratio exceeding 100% indicates that the company is paying out more in dividends than it generates in net income, which relies on cash flow or reserves and suggests the payout may not be fully sustainable if earnings growth stagnates or if cash flow deteriorates. For non-dividend payers, this would be the relevant metric, but since Kenvue pays a yield, the focus remains on the sustainability of the 4.8% yield given the high payout ratio. Overall, the growth and income profile presents a company with modest revenue expansion but accelerating earnings, coupled with a high-yield dividend that currently stretches beyond its reported net income generation.